title: Imatinib and altered bone and mineral metabolism.
authors.forename: Samantha
authors.initials: S
authors.lastname: Owen
authors.forename: Alan
authors.initials: A
authors.lastname: Hatfield
authors.forename: Laurie
authors.initials: L
authors.lastname: Letvak
mesh_terms: D001549:Benzamides; D015415:Biomarkers / Q000097:blood / Q000652:urine; D001842:Bone and Bones / Q000378:metabolism; D006801:Humans; D017674:Hypophosphatemia / Q000139:chemically induced*; D000068877:Imatinib Mesylate; D010710:Phosphates / Q000097:blood / Q000652:urine; D010879:Piperazines / Q000009:adverse effects*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D001549:Benzamides; D015415:Biomarkers; D010710:Phosphates; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate